Clinical Trial Update: In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the in vivo effects of C1-esterase inhibitor on the innate immune response during endotoxemia; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endotoxemia
• Sepsis

Drugs mentioned

• C1-esterase inhibitor

Snippet

Sponsor: Radboud University Medical Center | Conditions: Innate Immune Response, Endotoxemia | Phase 3 | Status: COMPLETED